Cargando…

The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI

BACKGROUND: Aortic stenosis (AS) can cause acquired von Willebrand syndrome (AVWS) and valve replacement has been shown to lead to von Willebrand factor (vWF) recovery. The aim of the current study was to investigate the prevalence of AVWS in different severe AS phenotypes and its course after trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Nastasia, Heidel, Carolin, Xu, Congde, Hubauer, Ute, Wallner, Stefan, Meindl, Christine, Holzamer, Andreas, Hilker, Michael, Creutzenberg, Marcus, Sossalla, Samuel, Maier, Lars, Jungbauer, Carsten, Debl, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681694/
https://www.ncbi.nlm.nih.gov/pubmed/35838799
http://dx.doi.org/10.1007/s00392-022-02047-6
_version_ 1784834677388869632
author Roth, Nastasia
Heidel, Carolin
Xu, Congde
Hubauer, Ute
Wallner, Stefan
Meindl, Christine
Holzamer, Andreas
Hilker, Michael
Creutzenberg, Marcus
Sossalla, Samuel
Maier, Lars
Jungbauer, Carsten
Debl, Kurt
author_facet Roth, Nastasia
Heidel, Carolin
Xu, Congde
Hubauer, Ute
Wallner, Stefan
Meindl, Christine
Holzamer, Andreas
Hilker, Michael
Creutzenberg, Marcus
Sossalla, Samuel
Maier, Lars
Jungbauer, Carsten
Debl, Kurt
author_sort Roth, Nastasia
collection PubMed
description BACKGROUND: Aortic stenosis (AS) can cause acquired von Willebrand syndrome (AVWS) and valve replacement has been shown to lead to von Willebrand factor (vWF) recovery. The aim of the current study was to investigate the prevalence of AVWS in different severe AS phenotypes and its course after transcatheter aortic valve implantation (TAVI). METHODS: 143 patients with severe AS undergoing TAVI were included in the study. vWF function was assessed at baseline, 6 and 24 h after TAVI. AVWS was defined as a reduced vWF:Ac/Ag ratio ≤ 0.7. Phenotypes were classified by tricuspid (TAV) and bicuspid (BAV) valve morphology, mean transvalvular gradient (P(mean)), stroke volume index (SVI), ejection fraction (EF) and indexed effective orifice area (iEOA). RESULTS: AVWS was present in 36 (25.2%) patients before TAVI. vWF:Ac/Ag ratio was significantly lower in high gradient compared to low-gradient severe AS [0.78 (IQR 0.67–0.86) vs. 0.83 (IQR 0.74–0.93), p < 0.05] and in patients with BAV compared to TAV [0.70 (IQR 0.63–0.78) vs. 0.81 (IQR 0.71–0.89), p < 0.05]. Normalization of vWF:Ac/Ag ratio was achieved in 61% patients 24 h after TAVI. As in the overall study cohort, vWF:Ac/Ag ratio increased significantly in all severe AS subgroups 6 h after TAVI (each p < 0.05). Regarding binary logistic regression analysis, BAV was the only significant predictor for AVWS. CONCLUSIONS: BAV morphology is a strong predictor for AVWS in severe AS. TAVI restores vWF function in most patients with severe AS independently of AS phenotype and valve morphology. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9681694
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96816942022-11-24 The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI Roth, Nastasia Heidel, Carolin Xu, Congde Hubauer, Ute Wallner, Stefan Meindl, Christine Holzamer, Andreas Hilker, Michael Creutzenberg, Marcus Sossalla, Samuel Maier, Lars Jungbauer, Carsten Debl, Kurt Clin Res Cardiol Original Paper BACKGROUND: Aortic stenosis (AS) can cause acquired von Willebrand syndrome (AVWS) and valve replacement has been shown to lead to von Willebrand factor (vWF) recovery. The aim of the current study was to investigate the prevalence of AVWS in different severe AS phenotypes and its course after transcatheter aortic valve implantation (TAVI). METHODS: 143 patients with severe AS undergoing TAVI were included in the study. vWF function was assessed at baseline, 6 and 24 h after TAVI. AVWS was defined as a reduced vWF:Ac/Ag ratio ≤ 0.7. Phenotypes were classified by tricuspid (TAV) and bicuspid (BAV) valve morphology, mean transvalvular gradient (P(mean)), stroke volume index (SVI), ejection fraction (EF) and indexed effective orifice area (iEOA). RESULTS: AVWS was present in 36 (25.2%) patients before TAVI. vWF:Ac/Ag ratio was significantly lower in high gradient compared to low-gradient severe AS [0.78 (IQR 0.67–0.86) vs. 0.83 (IQR 0.74–0.93), p < 0.05] and in patients with BAV compared to TAV [0.70 (IQR 0.63–0.78) vs. 0.81 (IQR 0.71–0.89), p < 0.05]. Normalization of vWF:Ac/Ag ratio was achieved in 61% patients 24 h after TAVI. As in the overall study cohort, vWF:Ac/Ag ratio increased significantly in all severe AS subgroups 6 h after TAVI (each p < 0.05). Regarding binary logistic regression analysis, BAV was the only significant predictor for AVWS. CONCLUSIONS: BAV morphology is a strong predictor for AVWS in severe AS. TAVI restores vWF function in most patients with severe AS independently of AS phenotype and valve morphology. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2022-07-15 2022 /pmc/articles/PMC9681694/ /pubmed/35838799 http://dx.doi.org/10.1007/s00392-022-02047-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Roth, Nastasia
Heidel, Carolin
Xu, Congde
Hubauer, Ute
Wallner, Stefan
Meindl, Christine
Holzamer, Andreas
Hilker, Michael
Creutzenberg, Marcus
Sossalla, Samuel
Maier, Lars
Jungbauer, Carsten
Debl, Kurt
The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI
title The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI
title_full The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI
title_fullStr The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI
title_full_unstemmed The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI
title_short The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI
title_sort impact of bicuspid aortic valve morphology on von willebrand factor function in patients with severe aortic stenosis and its change after tavi
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681694/
https://www.ncbi.nlm.nih.gov/pubmed/35838799
http://dx.doi.org/10.1007/s00392-022-02047-6
work_keys_str_mv AT rothnastasia theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT heidelcarolin theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT xucongde theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT hubauerute theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT wallnerstefan theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT meindlchristine theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT holzamerandreas theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT hilkermichael theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT creutzenbergmarcus theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT sossallasamuel theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT maierlars theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT jungbauercarsten theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT deblkurt theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT rothnastasia impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT heidelcarolin impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT xucongde impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT hubauerute impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT wallnerstefan impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT meindlchristine impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT holzamerandreas impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT hilkermichael impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT creutzenbergmarcus impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT sossallasamuel impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT maierlars impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT jungbauercarsten impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi
AT deblkurt impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi